Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1989-08-31
1993-01-12
Moezie, F. T.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 2, 514 21, 514561, 514 23, 514547, 514552, 514560, 424600, A61K 3736, A61K 3702
Patent
active
051790807
ABSTRACT:
Methods of treating malnutrition associated with chronic lung diseases comprising the administration of metabolically active peptides in an amount sufficient to increase circulating somatomedin C levels more than 0.8 U/ml plasma above the patient's baseline SmC level, along with nutritional supplementation providing a daily caloric intake of between 100% and 200% of the patient's baseline resting energy expenditure; and formulations utilized therein.
REFERENCES:
patent: 3697287 (1972-10-01), Winitz
patent: 3698912 (1972-10-01), Winitz
patent: 3793450 (1974-02-01), Schell
patent: 3853832 (1974-12-01), Li
patent: 3920838 (1975-11-01), Flatt et al.
patent: 3950529 (1976-04-01), Fischer et al.
patent: 4496689 (1985-01-01), Mitra
patent: 4497800 (1985-02-01), Larson et al.
patent: 4600582 (1986-07-01), Stevens et al.
patent: 4600583 (1986-07-01), Stevens et al.
patent: 4690820 (1987-09-01), Simko
patent: 4699897 (1987-10-01), Jones et al.
patent: 4775659 (1988-10-01), Thakkar
patent: 4786501 (1988-11-01), Janski
patent: 4791099 (1988-12-01), Aroonsakul
patent: 4801456 (1989-01-01), Drengler
patent: 4816437 (1989-03-01), Nimberg et al.
patent: 4863901 (1989-09-01), Wilmore
Machlin, Environmental Quality and Safety, vol. 5 (Supplement) 43-53, 1976.
Chalupa et al., Symposium on Nutrient Partitioning, California Animal Nutritution Conference, Fresno, CA., 1987.
Suchner et al., Anesthesiology, 69, A421, 1988.
Vandenberg, E., et al., Am. Rev. Respir. Dis., 95:556-566 (1967), "Weight Changes in the Terminal Stages of Chronic Obstructive Pulmonary Disease".
Burrows, B., et al., Am. Rev. Respir. Dis., 91:665-678 (1963), "Chronic Obstructive Lung Disease".
Tiech, S. (incorrectly cited as Rogers), et al., Chest, 85:635-665 (1984), "Azygos Lymph Node Enlargement as Initial Manifestation of Underlying Disease".
Goldstein, S., et al., Chest, 91:222-224 (1987), "Energy Expenditure in Patients with Chronic Obstructive Pulmonary Disease".
Sukumalchantra, Y., et al., Am. J. Med., 39:941-945 (1965), "Serial Studies of Pulmonary Function in Patients with Chronic Obstructive Pulmonary Disease".
Goldstein, S., et al., Am. Rev. Respir. Dis., 138:636-644 (1988), "Nitrogen and Energy Relationships in Malnourished Patients with Emphysema".
Askanazi, J., et al., Surgery, 87:596-598 (1980), "Respiratory Distress Secondary to a High Carbohydrate Load: A Case Report".
Li, C., et al., Science, 124:1293-1294 (1956), "Preparation and Properties of Growth Hormone from Human and Monkey Pituitary Glands".
Li, C., et al., J. Amer. Chem. Soc., 88:2050-2051 (1966), "Human Pituitary Growth Hormone, XII, The Amino Acid Sequence of the Hormone".
Atlas of Protein Sequence and Structure, vol. 5, Supp., 120-121 (1976).
Fryklund, L. M., et al., Clinics in Endocrinology and Metabolism, vol. 15, No. 3, 511-535 (1986), "Recombinant Human Growth Hormone".
Capdevielle, J., et al., Horm. Res., 24:225 (1986), "Characterization of Authentic Human Growth Hormone Produced in Escherichia coli".
Phares, C. K., J. Recept. Res., 8(5):645-665 (1988), "Use of Receptor Affinity Chromatography in Purification of the Growth Hormone-Like Factor Produced by Plerocercoids of the Tapeworm Spirometra Mansonoides".
The Merck Index, 10 ed., p. 1246, "Somatomedins".
D'Ercole, A. J. et al., Diabetes, 33:590-595 (1984), "Serum Somatomedin-C Concentrations in a Rabbit Model of Diabetic Pregnancy".
Harris et al., "A Biometric Study of the Basal Metabolism in Man", Carnegie Inst., Washington Pub., 279, pp. 223-250 (1919).
Elwyn, D. H., et al., Am. J. Clin. Nut., 32:1597-1611 (1979), "Changes in Nitrogen Balance of Depleted Patients With Increasing Infusions of Glucose".
Swift et al., Energy Metabolism and Nutrition, Scarecrow Press, Washington, DC (1954), pp. 3-4 and table of contents.
Gertz, I., et al., Clin. Sci. Mol. Med., 52:395-403 (1977), "Muscle Metabolism in Patients with Chronic Obstructive Lung Disease and Acute Respiratory Failure".
"Growth Hormone and Pulmonary Disease", Suchner, U., et al., Arch. Intern. Med., 150:1225-1230 (Jun. 1990).
Askanazi, J., Anesthesiology, 60(2):106-110 (1984), "Effect of Protein Intake on Ventilatory Drive".
Rochester, D. F., et al., Am. Rev. Respir. Dis., 119:151-154 (1979), "Respiratory Muscle Strength in Chronic Obstructive Pulmonary Disease".
Koruda, M. J., et al., IEEE Engineering in Medicine and Biology, 5:19-24 (1988).
Swift et al., Energy Metabolism and Nutrition, Scarecrow Press, Wash., DC, pp. 59-102 (1954).
Conzolazio et al., Physiological Measurements of Metabolic Function in Man, pp. 313-339 McGraw Hill, New York (1963).
Cave Bryan
Clinical Homecare, Corp.
Moezie F. T.
LandOfFree
Formulations containing growth hormone and nutritional supplemen does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Formulations containing growth hormone and nutritional supplemen, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Formulations containing growth hormone and nutritional supplemen will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1220237